Drug regulation

Digital

Health Technology Assessment – Challenges and opportunities ...

Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster

Market Access

Looking to history to prepare for America’s uncertain future

In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration

R&D

Continuing to keep COVID-19 at bay – the pharmaphorum podcas...

Flying into London recently for the Jefferies Conference, Novavax’s EVP, chief commercial officer, and chief business officer John Trizzino, together with the comp

Debates & Insight

Standing on the cusp of something great: How real-world data...

REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care

Views & Analysis

Piece in form of UK borders torn out from the flag of the European Union. United Kingdom withdrawal from the European Union. Brexit concept

Despite progress, Brexit still threatens UK with relegation ...

With time running out on Brexit, companies are already making long-term decisions.

Views & Analysis

Accessing biosimilars: untapped potential in EU and US

Though they can reduce the costs of health care, biosimilars still face challenges to access.